Atria Investments LLC Regeneron Pharmaceuticals, Inc. Transaction History

Atria Investments LLC

  • $7.56 Billion
  • Q3 2024

A detailed history of Atria Investments LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Atria Investments LLC holds 8,322 shares of REGN stock, worth $6.14 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
8,322
Previous 8,603 3.27%
Holding current value
$6.14 Million
Previous $9.04 Million 3.25%
% of portfolio
0.12%
Previous 0.12%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024
SELL
$1024.09 - $1201.76 $287,769 - $337,694
-281 Reduced 3.27%
8,322 $8.75 Million
Q2 2024

Aug 13, 2024
SELL
$883.2 - $1071.19 $47,692 - $57,844
-54 Reduced 0.62%
8,603 $9.04 Million
Q1 2024

May 21, 2024
BUY
$902.69 - $993.35 $849,431 - $934,742
941 Added 12.2%
8,657 $8.33 Million
Q4 2023

Feb 14, 2024
BUY
$775.18 - $881.7 $438,751 - $499,042
566 Added 7.92%
7,716 $6.78 Million
Q3 2023

Nov 07, 2023
SELL
$692.45 - $844.37 $290,829 - $354,635
-420 Reduced 5.55%
7,150 $5.88 Million
Q2 2023

Aug 04, 2023
SELL
$700.03 - $830.35 $268,111 - $318,024
-383 Reduced 4.82%
7,570 $5.44 Million
Q1 2023

May 10, 2023
BUY
$680.49 - $826.97 $200,744 - $243,956
295 Added 3.85%
7,953 $6.53 Million
Q4 2022

Jan 31, 2023
SELL
$705.89 - $766.39 $412,945 - $448,338
-585 Reduced 7.1%
7,658 $5.53 Million
Q3 2022

Nov 01, 2022
BUY
$573.97 - $724.32 $185,966 - $234,679
324 Added 4.09%
8,243 $5.68 Million
Q2 2022

Aug 11, 2022
SELL
$548.35 - $738.84 $624,022 - $840,799
-1,138 Reduced 12.56%
7,919 $4.68 Million
Q1 2022

May 02, 2022
SELL
$595.12 - $698.43 $590,359 - $692,842
-992 Reduced 9.87%
9,057 $6.33 Million
Q4 2021

Feb 04, 2022
BUY
$543.48 - $670.97 $1.07 Million - $1.32 Million
1,961 Added 24.25%
10,049 $6.35 Million
Q3 2021

Nov 16, 2021
SELL
$574.03 - $680.96 $200,336 - $237,655
-349 Reduced 4.14%
8,088 $4.9 Million
Q2 2021

Aug 10, 2021
BUY
$472.8 - $558.54 $135,220 - $159,742
286 Added 3.51%
8,437 $4.71 Million
Q1 2021

May 11, 2021
SELL
$446.73 - $548.2 $917,136 - $1.13 Million
-2,053 Reduced 20.12%
8,151 $3.86 Million
Q4 2020

Feb 12, 2021
SELL
$478.3 - $607.98 $64,092 - $81,469
-134 Reduced 1.3%
10,204 $4.93 Million
Q3 2020

Nov 05, 2020
SELL
$544.75 - $658.21 $3.86 Million - $4.67 Million
-7,088 Reduced 40.67%
10,338 $5.79 Million
Q2 2020

Sep 22, 2020
BUY
$493.32 - $643.92 $3.49 Million - $4.56 Million
7,075 Added 68.35%
17,426 $10.9 Million
Q1 2020

May 15, 2020
BUY
$336.18 - $494.43 $879,446 - $1.29 Million
2,616 Added 33.82%
10,351 $5.05 Million
Q4 2019

Feb 11, 2020
BUY
$274.13 - $376.51 $1.86 Million - $2.56 Million
6,800 Added 727.27%
7,735 $2.9 Million
Q3 2019

Nov 14, 2019
BUY
$273.46 - $318.39 $29,260 - $34,067
107 Added 12.92%
935 $259,000
Q2 2019

Aug 26, 2019
BUY
$299.6 - $414.82 $248,068 - $343,470
828 New
828 $248,000
Q2 2019

Aug 09, 2019
SELL
$299.6 - $414.82 $229,194 - $317,337
-765 Closed
0 $0
Q1 2019

May 15, 2019
BUY
$372.08 - $439.57 $15,627 - $18,461
42 Added 5.81%
765 $314,000
Q4 2018

Feb 12, 2019
SELL
$335.82 - $403.04 $135,335 - $162,425
-403 Reduced 35.79%
723 $270,000
Q3 2018

Oct 09, 2018
SELL
$351.14 - $408.51 $130,272 - $151,557
-371 Reduced 24.78%
1,126 $455,000
Q2 2018

Jul 13, 2018
BUY
$284.6 - $344.99 $41,836 - $50,713
147 Added 10.89%
1,497 $516,000
Q1 2018

Apr 30, 2018
SELL
$315.82 - $393.78 $183,175 - $228,392
-580 Reduced 30.05%
1,350 $465,000
Q4 2017

Jan 16, 2018
BUY
$358.63 - $469.95 $232,033 - $304,057
647 Added 50.43%
1,930 $726,000
Q3 2017

Oct 12, 2017
BUY
$431.38 - $504.0 $553,460 - $646,632
1,283
1,283 $574,000

Others Institutions Holding REGN

# of Institutions
1,531
Shares Held
84.1M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $79.1B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Atria Investments LLC Portfolio

Follow Atria Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atria Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atria Investments LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email